Clearside Biomedical, Inc.CLSDNASDAQ
Loading
Operating Expenses Over TimeStable
Percentile Rank58
3Y CAGR+0.2%
5Y CAGR-1.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+0.2%/yr
vs -15.3%/yr prior
5Y CAGR
-1.3%/yr
Consistent
Acceleration
+15.5pp
Accelerating
Percentile
P58
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $30.40M | -7.1% |
| 2023 | $32.72M | +4.2% |
| 2022 | $31.40M | +4.0% |
| 2021 | $30.20M | +16.9% |
| 2020 | $25.83M | -20.5% |
| 2019 | $32.48M | -60.9% |
| 2018 | $82.97M | +41.2% |
| 2017 | $58.75M | +128.5% |
| 2016 | $25.72M | +48.5% |
| 2015 | $17.32M | - |